ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.07 -0.05 (-1.21%)
At close: Oct 2, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Price to Earnings (2022 - 2024)

Updated

ARS Pharmaceuticals' Price to Earnings came in at 129.21 for Q4 2024.

Analysis

ARS Pharmaceuticals (SPRY) Price to Earnings (2022 - 2024) Analysis & Trends

  • The Q4 2024 figure represents the lowest quarterly Price to Earnings since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 ARS Pharmaceuticals 404.71 Mn 260.91 Mn 20.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 129.21
Sep 30, 2022 7.42
Jun 30, 2022 15.78
API Access

ARS Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SPRY&period=max&api_key=YOUR_API_KEY